TSX:CMED - Toronto Stock Exchange -
TSX:CMED (5/1/2018, 4:30:00 PM)
27
-1.5 (-5.26%)
The current stock price of CMED.CA is 27 null. In the past month the price decreased by -17.13%. In the past year, price increased by 138.94%.
CanniMed Therapeutics Inc is a biopharmaceutical company. The principal business activities of CanniMed along with its subsidiaries is plant biotechnology research, product development and the production of plant based materials.
Cannimed Therapeutics Inc
1 Plant Technology Road
Saskatoon SK S7K 3J8
CEO: Brent Zettl
Phone: +1 855 787-1577
The current stock price of CMED.CA is 27 null. The price decreased by -5.26% in the last trading session.
The exchange symbol of Cannimed Therapeutics Inc is CMED and it is listed on the Toronto Stock Exchange exchange.
CMED.CA stock is listed on the Toronto Stock Exchange exchange.
Cannimed Therapeutics Inc (CMED.CA) has a market capitalization of 668.44M null. This makes CMED.CA a Small Cap stock.
Cannimed Therapeutics Inc (CMED.CA) has a support level at 13.91 and a resistance level at 27.01. Check the full technical report for a detailed analysis of CMED.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CMED.CA does not pay a dividend.
The PE ratio for Cannimed Therapeutics Inc (CMED.CA) is 245.45. This is based on the reported non-GAAP earnings per share of 0.11 and the current share price of 27 null. Check the full fundamental report for a full analysis of the valuation metrics for CMED.CA.
ChartMill assigns a technical rating of 2 / 10 to CMED.CA. When comparing the yearly performance of all stocks, CMED.CA is one of the better performing stocks in the market, outperforming 91.46% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to CMED.CA. CMED.CA has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months CMED.CA reported a non-GAAP Earnings per Share(EPS) of 0.11. The EPS increased by 103.82% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 15% | ||
ROA | 2.18% | ||
ROE | 2.76% | ||
Debt/Equity | 0.1 |